ArticleScientific reports2025
Dairy consumption and premature coronary artery disease onset: Iran premature coronary artery disease (IPAD) study insights.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Evidence has argued about the association between dairy intake and premature coronary artery disease (PCAD) development aimed to be discussed in this study. This case-control study was conducted on 813 individuals with PCAD and 471 healthy controls. The dairy intake of participants was assessed by a validated semi-quantitative food frequency questionnaire. Binary and ordinal logistic regression was applied to determine the association of dairy intake with PCAD and its severity, respectively. Compared to the first quartile, the highest quartile of total dairy consumption was associated with an increased risk of PCAD [Odds ratio (OR):1.56; 95% confidence interval (95%CI): 1.13, 2.14; P = 0.008] in the crude model. It was strengthened after full adjustment [OR: 2.44, 95% CI; 1.50,3.97; P < 0.001]. Both low-fat and high-fat dairy intake revealed no association with the risk of PCAD in the crude model. However, in the fully adjusted model, respectively highest quartile of high-fat and low-fat dairy intake had a relationship with a higher risk of SCAD. [(OR:1.68; 95%CI: 1.05,2.69; P-value for trend = 0.011) and (OR:1.99; 95%CI: 1.20,3.27; P-value for trend = 0.005). After adjustment for potential confounders, the highest amount of intake of high-fat dairy was related to increased severity of PCAD (OR:1.84; 95%CI: 1.27,2.68), but not for total and low-fat dairy intake (OR:0.98; 95%CI: 0.67,1.44 and OR: 0.74; 0.51,1.07; respectively). Dairy consumption regardless of its fat content was associated with increased risk for PCAD. The severe atherosclerotic manifestations in the coronary arteries were only associated with higher intake of high-fat dairy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.